From inpatient to outpatient mental health care: a randomised controlled feasibility trial of a care transition intervention for patients with depression and anxiety

From inpatient to outpatient mental health care: a randomised controlled feasibility trial of a care transition intervention for patients with depression and anxiety - AMBITION

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029381

Enrollment

Registered

2022-07-14

Start date

2022-08-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00-F99

Interventions

Group 1: The intervention group receives five appointments with a Care Transition Manager to support them in arranging for follow-up outpatient treatment. During the appointments, barriers are identif

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - recommendation by the treating ward mental health specialists to start an outpatient psychosocial follow-up treatment - being treated for at least a moderate depressive and/or anxiety disorder - Informed Consent documented in writing - ability to give consent - completed 18th year of life

Exclusion criteria

Exclusion criteria: - already planned resumption of outpatient psychotherapy after the inpatient stay - acute psychotic symptoms, e.g. persecutory delusions and/or thought insertion - dementia and/or severe cognitive impairment - significant hearing and/or visual impairment - pregnancy in the 2nd or 3rd trimester - insufficient German language skills

Design outcomes

Primary

Measure	Time frame
The study evaluates the feasibility of the following aspects: sufficiency and efficiency of recruitment strategies for intervention and control group, recruitment and attrition rates for intervention and control group, patient acceptance of outcome measurements, feasibility of study procedures (e.g. patient acceptance of randomisation and outcome measurements), feasibility of intervention procedures (including the necessary documentation, implementation loyalty, patient acceptance of video consultations, patient safety).	—

Measure

Time frame

The study evaluates the feasibility of the following aspects: sufficiency and efficiency of recruitment strategies for intervention and control group, recruitment and attrition rates for intervention and control group, patient acceptance of outcome measurements, feasibility of study procedures (e.g. patient acceptance of randomisation and outcome measurements), feasibility of intervention procedures (including the necessary documentation, implementation loyalty, patient acceptance of video consultations, patient safety).

—

Secondary

Measure	Time frame
No secondary endpoint is defined in the conventional sense. In addition to feasibility, the following endpoints are evaluated: - Mental symptom burden (Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS) for Depression and for anxiety disorders, Somatic Symptom Disorder–B Criteria Scale (SSD-12) for Somatic Symptom Disorder) - Recovery (Recovery Assessment Scale, RAS-G) - Quality of life (SF-12) - health economic parameters (Questionnaire for the Assessment of Medical and non Medical Resource Utilisation in Mental Disorders, FIMPsy)	—

Measure

Time frame

No secondary endpoint is defined in the conventional sense. In addition to feasibility, the following endpoints are evaluated: - Mental symptom burden (Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS) for Depression and for anxiety disorders, Somatic Symptom Disorder–B Criteria Scale (SSD-12) for Somatic Symptom Disorder) - Recovery (Recovery Assessment Scale, RAS-G) - Quality of life (SF-12) - health economic parameters (Questionnaire for the Assessment of Medical and non Medical Resource Utilisation in Mental Disorders, FIMPsy)

—

Countries

Germany

Contacts

Public ContactMarkus Haun

Universitätsklinikum Heidelberg

markus.haun at med.uni-heidelberg.de06221 56 38396

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026